Hikma upgrades FY guidance, cautious on Sudan impact : vimar

Hikma Pharmaceuticals upgraded full-year guidance after a stronger-than-expected start to the year for its generics business but expressed concern about the impact of the current conflict in Sudan on operations.

Related Keywords

Sudan , , Shikma , Upgrades , Guidance , Cautious , Impact , Category All , Category Company News , Category News And Announcements , Category Ifa News Round Up , Category Headline News , Category Fidelity Top Stories , Category Sectorial Health Technology ,